4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-065839
Chief Scientific Officer sold 4,000 shares at an average $32.00 ($127,993)
- Chief Scientific Officer acquired 4,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS HARLAN S · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-17 | Exercise or conversion : show line 1 in the form | +3,700 | $6.55 | $24,235 | 73,060 | D |
| 2021-11-17 | Sale : show line 2 in the form | −3,700 | $32.05 | $118,585 | 69,360 | D |
| 2021-11-18 | Exercise or conversion : show line 3 in the form | +300 | $6.55 | $1,965 | 69,660 | D |
| 2021-11-18 | Sale : show line 4 in the form | −300 | $31.36 | $9,408 | 69,360 | D |
| Open-market sales · 4,000 sh · avg $32.00 · $127,993 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-17 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −3,700 | 285,100 | D |
| 2021-11-18 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −300 | 284,800 | D |
Loading xslF345X03/doc4.xml…